Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 10/2011

01-10-2011 | Letter to the Editor

Echinococcus multilocularis infection and TNF inhibitor treatment in a patient with rheumatoid arthritis

Authors: S. M. Weiner, V. Krenn, C. Koelbel, H. G. Hoffmann, K. Hinkeldey, D. Ockert

Published in: Rheumatology International | Issue 10/2011

Login to get access

Excerpt

Sir, …
Literature
1.
Furst DE, Keystone EC, Kirkham B, Kavanaugh A, Fleischmann R, Mease P et al (2008) Updated consensus statement on biological agents for the treatment of rheumatic diseases. Ann Rheum Dis 67(Suppl 3):2–25CrossRef
2.
Haralabidis S, Karagouni E, Frydas S, Dotsika E (1995) Immunoglobulin and cytokine profile in murine secondary hydatidosis. Parasite Immunol 17:625–630PubMedCrossRef
3.
Al-Qaoud KM, Abdel-Hafez SK (2008) The induction of T helper type 1 response by cytokine gene transfection protects mice against secondary hydatidosis. Parasitol Res 102:1151–1155PubMedCrossRef
4.
Bresson-Hadni S, Petitjean O, Monnot-Jacquard B, Heyd B, Kantelip B, Deschaseaux M et al (1994) Cellular localisations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha mRNA in a parasitic granulomatous disease of the liver, alveolar echinococcosis. Eur Cytokine Netw 5:461–468PubMed
5.
6.
Baz A, Richieri A, Puglia A, Nieto A, Dematteis S (1999) Antibody response in CD4-depleted mice after immunization or during early infection with echinococcus granulosus. Parasite Immunol 21:141–150PubMedCrossRef
7.
Deplazes P (2006) Ecology and epidemiology of echinococcus multilocularis in Europe. Parassitologia 48:37–39PubMed
8.
Dyachenko V, Pantchev N, Gawlowska S, Vrhovec MG, Bauer C (2008) Echinococcus multilocularis infections in domestic dogs and cats from Germany and other European countries. Vet Parasitol 157:244–253PubMedCrossRef
9.
Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P (2000) Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother 46:451–456PubMedCrossRef
10.
Colebrook AL, Jenkins DJ, Jones MK, Tatarczuch L, Lightowlers MW (2004) Effect of cyclosporin A on the survival and ultrastructure of Echinococcus granulosus protoscoleces in vitro. Parasitology 129:497–504PubMedCrossRef
Metadata
Title
Echinococcus multilocularis infection and TNF inhibitor treatment in a patient with rheumatoid arthritis
Authors
S. M. Weiner
V. Krenn
C. Koelbel
H. G. Hoffmann
K. Hinkeldey
D. Ockert
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1570-7

Other articles of this Issue 10/2011

Rheumatology International 10/2011 Go to the issue

Case Report

Unusual central nervous system involvement of rheumatoid arthritis: successful treatment with steroid and azathioprine

Original Article

Variations in chondrocyte apoptosis may explain the increased prevalence of osteoarthritis in some joints

Letter to the Editor

Failure of a metal on metal hip prostheses presenting as a destructive soft tissue mass due to ALVAL

Editorial

Progress in pediatric rheumatology: apprehend the opportunities of the future without forgetting the lessons from the past

Original Article

Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis

Original Article

Whole-body MRI in the childhood form of hypophosphatasia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits